ANP and BNP: The Useful Cardiac Markers


ANP and BNP are both produced by the heart. They are important in regulating blood pressure and fluid balance in the body. ANP is produced in the atria, whilst BNP is produced in the ventricles of the heart. Both are released in response to increased pressure and volume in the heart, which occurs in conditions such as heart failure and hypertension. Due to their physiological functions and dynamic changes in response to cardiac stress, both of them have become useful markers in the diagnosis and management of cardiovascular diseases.

ANP and BNP are natriuretic peptides, which means they promote the excretion of sodium and water from the body. This helps to reduce blood volume and pressure and it prevent the formation of edema. In heart failure, the production of ANP and BNP is increased as the heart struggles to pump blood effectively. Elevated levels present in the blood is used as diagnostic and prognostic markers for; heart failure, hypertension and coronary artery disease.

Mechanisms of Action

ANP and BNP exert their effects through binding to specific receptors located on various tissues throughout the body. These as known as natriuretic peptide receptors (NPRs). They are found in the; heart, blood vessels, kidneys, and other organs. Upon binding to their respective receptors, this activates of a signalling pathway that leads the production of cyclic guanosine monophosphate (cGMP).

One of the primary mechanisms of ANP and BNP is the promotion of natriuresis or the excretion of sodium and water by the kidneys. The process is carried using several different mechanisms for example; increasing glomerular filtration rate, suppressing the renin-angiotensin-aldosterone system (RAAS), inhibiting sodium and water reabsorption in the renal tubules.

They both display vasodilatory effects; it helps to lower blood pressure and improve blood flow. This is achieved through relaxation of smooth muscle cells in blood vessel walls, which reduces vascular resistance and increases vascular permeability.

Clinical Applications

ANP and BNP have several clinical applications in the diagnosis and management of cardiovascular diseases. It is extremely important in the diagnosis of heart failure, this is displayed by elevated levels being present in the blood. They are also used to determine the severity of heart failure and to monitor the response following the treatment process. Studies investigating the levels have found a direct correlation between the degree of left ventricular dysfunction and the mortality or hospitalization in patients with heart failure.  Monitoring changes in ANP and BNP levels over time can provide valuable information about the effectiveness of treatment and help guide clinical decision-making.

ANP and BNP have also been used in the diagnosis and management of other cardiovascular diseases such as; hypertension and coronary artery disease. Elevated levels are often seen in these conditions and can be used to predict adverse outcomes and guide treatment decisions.

Limitations and Challenges as Cardiac Markers

Despite their many clinical applications, there are several limitations and challenges to the use of ANP and BNP as cardiac markers.  The lack of standardization in the measurement of these markers. Different assay methods and reference ranges can lead to variations in reported levels, making it difficult to compare results across different laboratories or studies.

Another limitation is the variability in levels seen in different populations and in response to different stimuli. These levels are affected by; age, sex, body mass index and renal function. This can make it difficult to interpret results and determine appropriate cut-off values for diagnosis or monitoring. Furthermore, they can be affected by factors such; as pulmonary disease, liver disease and sepsis.

Finally, the cost and availability of ANP and BNP assays can be a limiting factor in their use, particularly in resource-limited settings. Despite these challenges, ANP and BNP remain valuable tools in the diagnosis and management of cardiovascular diseases.

Related ELISA Kits

Cardiac Markers ELISA Kits:

ACE2, ANP, BNP, Cardiac Troponin I, Cardiotrophin-1, CK-MB, CRP, Haptoglobin, Homocysteine, hs-CRP, hs-cTN, Lipocalin-2, Malondialdehyde, MyoglobinNT-proBNP, PAI-1, Procalcitonin, Superoxide Dismutase, Troponin T

Online Enquiry Form

"*" indicates required fields

Please check mark information required:


Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford